AFP and hepatocellular carcinoma: Despite the commonly used Alpha-fetoprotein (AFP) as a serum tumor marker, for diagnosis and follow-up of HCV-associated HCC in high-risk individuals5, the predictive performance reported increased AFP levels in 60–70% of HCC patients with cirrhosis6.